Pharmacokinetics
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-16.png)
Naïve, protein-naïve and non-naïve study subjects with potential distinct genetic, clinical and immunological phenotypes.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-03.png)
Enzyme(s) induction and drug-drug interaction studies.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-14.png)
Standard, non-standard and surgical routes of administration (oral, intravenous, subcutaneous, spinal, parenteral, intracerebral, cisternal, ocular, gastric tract)
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-13.png)
Pre-formulated liquid or solid dosage forms.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-10.png)
Dose formulation for liquid forms (sterile or non-sterile) with sample retention for analysis.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-08.png)
Tissue-specific drug levels by biosampling, biopsy or microdialysis (cerebrospinal fluid, liver, muscle, skin).
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-06.png)
Acute, short-infusion or repeated dosing using experimental or latin-square study designs.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-01.png)
Standard and extended-time tissue samples collection for small molecules and biologics with or without recovery phase.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-12.png)
Standard, dose escalation and dose tolerability drug exposure levels.
![Image](https://www.envolbio.com/wp-content/uploads/2023/10/Envol_Icons-03.png)
Drug disposition assessment using metabolic sampling, including bile secretion.